78 related articles for article (PubMed ID: 11238117)
1. Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells.
Wen YJ; Barlogie B; Yi Q
Blood; 2001 Mar; 97(6):1750-5. PubMed ID: 11238117
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models.
Corthay A; Lundin KU; Munthe LA; Frøyland M; Gedde-Dahl T; Dembic Z; Bogen B
Cancer Immunol Immunother; 2004 Sep; 53(9):759-69. PubMed ID: 15088126
[TBL] [Abstract][Full Text] [Related]
3. A stable single-chain variable fragment expressing transfectoma demonstrates induction of idiotype-specific cytotoxic T-cells during early growth stages of a murine B-lymphoma.
Laxmanan S; Stuart GW; Ghosh SK
Cancer Immunol Immunother; 2001 Oct; 50(8):437-44. PubMed ID: 11726138
[TBL] [Abstract][Full Text] [Related]
4. Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma.
Kobayashi T; Yamanaka R; Homma J; Tsuchiya N; Yajima N; Yoshida S; Tanaka R
Cancer Immunol Immunother; 2003 Oct; 52(10):632-7. PubMed ID: 12827308
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors.
Bae J; Hideshima T; Tai YT; Song Y; Richardson P; Raje N; Munshi NC; Anderson KC
Leukemia; 2018 Sep; 32(9):1932-1947. PubMed ID: 29487385
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.
Hájek R; Butch AW
Med Oncol; 2000 Feb; 17(1):2-15. PubMed ID: 10713654
[TBL] [Abstract][Full Text] [Related]
7. Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cells.
Martorelli D; Coppotelli G; Muraro E; Dolcetti R; Masucci MG
Cancer Immunol Immunother; 2012 Jun; 61(6):881-92. PubMed ID: 22089857
[TBL] [Abstract][Full Text] [Related]
8. Light chain myeloma plasma cells induce a strong cell-mediated immune response mainly directed against the monoclonal light chain determinants in a murine experimental model.
Galea HR; Denizot Y; Cogné M
Cancer Immunol Immunother; 2002 Jun; 51(4):229-34. PubMed ID: 12012110
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein impairs immune response of CD8
Jiang J; Peng Z; Wang J; Chen M; Wan Y; Huang H; Liu Z; Wang J; Hou J
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37844994
[TBL] [Abstract][Full Text] [Related]
10. Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients.
Maecker B; von Bergwelt-Baildon MS; Anderson KS; Vonderheide RH; Anderson KC; Nadler LM; Schultze JL
Clin Exp Immunol; 2005 Sep; 141(3):558-62. PubMed ID: 16045747
[TBL] [Abstract][Full Text] [Related]
11. CD4
Bogen B; Fauskanger M; Haabeth OA; Tveita A
Cancer Immunol Immunother; 2019 Nov; 68(11):1865-1873. PubMed ID: 31448380
[TBL] [Abstract][Full Text] [Related]
12. Generation of T cell clones binding F(ab')2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy.
Osterborg A; Masucci M; Bergenbrant S; Holm G; Lefvert AK; Mellstedt H
Cancer Immunol Immunother; 1991; 34(3):157-62. PubMed ID: 1756532
[TBL] [Abstract][Full Text] [Related]
13. Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma.
Brimnes MK; Svane IM; Johnsen HE
Clin Exp Immunol; 2006 Apr; 144(1):76-84. PubMed ID: 16542368
[TBL] [Abstract][Full Text] [Related]
14. Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes.
Iaccino E; Mimmi S; Dattilo V; Marino F; Candeloro P; Di Loria A; Marimpietri D; Pisano A; Albano F; Vecchio E; Ceglia S; Golino G; Lupia A; Fiume G; Quinto I; Scala G
Mol Cancer; 2017 Oct; 16(1):159. PubMed ID: 29029605
[TBL] [Abstract][Full Text] [Related]
15. Immune therapies.
Prabhala RH; Munshi NC
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1217-30, x-xi. PubMed ID: 17996595
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specificity of oligoclonal abnormal protein bands in multiple myeloma after allogeneic stem cell transplantation.
Rahlff J; Trusch M; Haag F; Bacher U; Horst A; Schlüter H; Binder M
Cancer Immunol Immunother; 2012 Oct; 61(10):1639-51. PubMed ID: 22350072
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies.
Lagreca I; Nasillo V; Barozzi P; Castelli I; Basso S; Castellano S; Paolini A; Maccaferri M; Colaci E; Vallerini D; Natali P; Debbia D; Pirotti T; Ottomano AM; Maffei R; Bettelli F; Giusti D; Messerotti A; Gilioli A; Pioli V; Leonardi G; Forghieri F; Bresciani P; Cuoghi A; Morselli M; Manfredini R; Longo G; Candoni A; Marasca R; Potenza L; Tagliafico E; Trenti T; Comoli P; Luppi M; Riva G
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765928
[TBL] [Abstract][Full Text] [Related]
18. The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches.
Lagreca I; Riva G; Nasillo V; Barozzi P; Castelli I; Basso S; Bettelli F; Giusti D; Cuoghi A; Bresciani P; Messerotti A; Gilioli A; Pioli V; Colasante C; Vallerini D; Paolini A; Maccaferri M; Donatelli F; Forghieri F; Morselli M; Colaci E; Leonardi G; Marasca R; Potenza L; Manfredini R; Tagliafico E; Trenti T; Comoli P; Luppi M
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563634
[TBL] [Abstract][Full Text] [Related]
19. The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy.
Puttemans J; Stijlemans B; Keyaerts M; Vander Meeren S; Renmans W; Fostier K; Debie P; Hanssens H; Rodak M; Pruszynski M; De Veirman K; Vanderkerken K; Lahoutte T; Morgenstern A; Bruchertseifer F; Devoogdt N; D'Huyvetter M
Mol Cancer Ther; 2022 Jan; 21(1):159-169. PubMed ID: 34667109
[TBL] [Abstract][Full Text] [Related]
20. A Possible Role for Idiotype/Anti-idiotype B-T Cell Interactions in Maintaining Immune Memory.
Seledtsov VI; Seledtsova GV
Front Immunol; 2017; 8():409. PubMed ID: 28428787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
